| Product Code: ETC7652656 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Glycopeptide Antibiotics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Glycopeptide Antibiotics Market - Industry Life Cycle |
3.4 Israel Glycopeptide Antibiotics Market - Porter's Five Forces |
3.5 Israel Glycopeptide Antibiotics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Israel Glycopeptide Antibiotics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Glycopeptide Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Glycopeptide Antibiotics Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Glycopeptide Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Glycopeptide Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing awareness about the effectiveness of glycopeptide antibiotics in treating infections |
4.2.3 Rising investments in healthcare infrastructure and RD activities in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of glycopeptide antibiotics |
4.3.2 High cost associated with the development and production of glycopeptide antibiotics |
5 Israel Glycopeptide Antibiotics Market Trends |
6 Israel Glycopeptide Antibiotics Market, By Types |
6.1 Israel Glycopeptide Antibiotics Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Vancomycin, 2021- 2031F |
6.1.4 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Dalbavancin, 2021- 2031F |
6.1.5 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Oritavancin, 2021- 2031F |
6.1.6 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Glycopeptide Antibiotics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Skin and Structure Infection, 2021- 2031F |
6.2.3 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.2.4 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Clostridioides Difficile Infection, 2021- 2031F |
6.2.5 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Enterocolitis, 2021- 2031F |
6.2.6 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Glycopeptide Antibiotics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Glycopeptide Antibiotics Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Glycopeptide Antibiotics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Israel Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Glycopeptide Antibiotics Market Import-Export Trade Statistics |
7.1 Israel Glycopeptide Antibiotics Market Export to Major Countries |
7.2 Israel Glycopeptide Antibiotics Market Imports from Major Countries |
8 Israel Glycopeptide Antibiotics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for glycopeptide antibiotics in Israel |
8.2 Percentage of healthcare professionals recommending glycopeptide antibiotics |
8.3 Rate of adoption of glycopeptide antibiotics in hospitals and clinics |
9 Israel Glycopeptide Antibiotics Market - Opportunity Assessment |
9.1 Israel Glycopeptide Antibiotics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Israel Glycopeptide Antibiotics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Glycopeptide Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Glycopeptide Antibiotics Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Glycopeptide Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Glycopeptide Antibiotics Market - Competitive Landscape |
10.1 Israel Glycopeptide Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 Israel Glycopeptide Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here